Do you want to link to this External Website and leave

YOU ARE NOW LEAVING THIS WEBSITE. Amgen Netherlands takes no responsibility for, and exercises no control over, the organizations, views, or accuracy of the information contained on this server or site.

Code underlines social responsibility

The Dutch innovative medicines sector has a Code as of January 1, 2020, which clarifies the principles of the sector and what the sector stands for. All drug companies that are members of the Association Innovative Medicines, including Amgen, have signed the Code. With this, the sector underlines its social responsibility.

The Code contains agreements on integrity, transparency, social responsibility and quality. It is a form of self-regulation, which is not without obligation. Unique is the independent Advisory Board that monitors if members adhere to the Code. In addition, the college can provide solicited and unsolicited advice so that the Code can develop further. The Advisory Board publishes also a public annual report.

Based on the findings of the Advisory Board, the Code can be adjusted annually.

Click here to read the Code

In this section

Amgen Foundationicon

The Amgen Foundation seeks to inspire the next generation of innovators. Learn more about the Foundation's commitment to the scientists of tomorrow, here

Code VIGicon

The Code of conduct of the Association Innovative Medicines clarifies the principles of the Dutch innovative medicines sector and what the sector stands for. Amgen has also signed this Code.